Monoclonal antibodies targeting the calcitonin gene-related peptide pathway improve the effectiveness of acute medication-a real-world study.

Chiara RosignoliValeria CaponnettoAgnese OnofriVittorio TrozziLorenzo TartaglioneMarcello SilvestroAntonio RussoSimona SaccoRaffaele Ornello

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)

We showed that 6 months of preventive treatment with CGRP-mAbs led to a significantly better effectiveness of acute treatments, paralleled by decreased monthly migraine days and acute treatment intake.

Keyphrases

liver failure
respiratory failure
randomized controlled trial
systematic review
healthcare
hepatitis b virus
drug delivery
physical activity
body mass index
combination therapy
mechanical ventilation
acute respiratory distress syndrome